Chemoinformaics analysis of 1,6,7-Trimethylnaphthalene
| Molecular Weight | 170.255 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 11 |
| Exact Molecular Weight | 170.11 | nRing | 2 |
| Solubility: LogS | -5.637 | nHRing | 0 |
| Solubility: LogP | 4.7 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 0 | APOL | 31.0451 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.564 |
| Synth | 1.672 |
| Natural Product Likeliness | -0.182 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.087 |
| Pgp-sub | 0.275 |
| HIA | 0.006 |
| CACO-2 | -4.593 |
| MDCK | 0.0000186 |
| BBB | 0.818 |
| PPB | 0.966695 |
| VDSS | 0.848 |
| FU | 0.0203959 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.945 |
| CYP2c19-inh | 0.815 |
| CYP2c19-sub | 0.696 |
| CYP2c9-inh | 0.435 |
| CYP2c9-sub | 0.825 |
| CYP2d6-inh | 0.686 |
| CYP2d6-sub | 0.936 |
| CYP3a4-inh | 0.366 |
| CYP3a4-sub | 0.444 |
| CL | 9.639 |
| T12 | 0.178 |
| hERG | 0.037 |
| Ames | 0.769 |
| ROA | 0.039 |
| SkinSen | 0.766 |
| Carcinogencity | 0.838 |
| EI | 0.996 |
| Respiratory | 0.042 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.641737 |